Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy

Autor: Rosanna Coppo, Francesco Emma, François Berthoux, Kensuke Joh, Haiyan Wang, Daniel C. Cattran, Giuseppe D'Amico, F. Paolo Schena, Franco Ferrario, Olga Vorobyeva, Shubha Bellur, Fernand Mac-Moune Lai, N Yoshikawa, Stéphan Troyanov, Alessandro Amore, Vivette D. D'Agati, Jan J. Weening, Stephen I-Hong Hsu, Charles E. Alpers, Jonathan Barratt, J. Charles Jennette, Fanny Lepeytre, Fernando C. Fervenza, John Feehally, Sandrine Florquin, Agnes B. Fogo, Tetsuya Kawamura, Bruce Mackinnon, H. Terence Cook, Hong Zhang, Zhihong Liu, Philip Kam-Tao Li, Mark Haas, Jan A. Bruijn, Colin C. Geddes, Ian Roberts, Ronald J. Hogg, Hermann-Josef Groene, Lei-Shi Li, Prue Hill, Steven N. Emancipator, Andrew M. Herzenberg, Yasuhiko Tomino, Sergio Mezzano, Stephen M. Bonsib, Bruce A. Julian, Patrick D. Walker
Přispěvatelé: Pathology
Rok vydání: 2017
Předmět:
Male
Pathology
Biopsy
medicine.medical_treatment
030232 urology & nephrology
Kaplan-Meier Estimate
VARIANTS
030204 cardiovascular system & hematology
urologic and male genital diseases
podocytopathy
Podocyte
Muscle hypertrophy
0302 clinical medicine
Focal segmental glomerulosclerosis
Child
Proteinuria
medicine.diagnostic_test
PODOCYTE
Glomerulosclerosis
Focal Segmental

Podocytes
Immunosuppression
IgA nephropathy
Urology & Nephrology
Middle Aged
Prognosis
medicine.anatomical_structure
Nephrology
TRIAL
Female
medicine.symptom
Life Sciences & Biomedicine
Glomerular Filtration Rate
Adult
medicine.medical_specialty
Adolescent
segmental sclerosis
Renal function
Nephropathy
Young Adult
03 medical and health sciences
medicine
Humans
Retrospective Studies
Immunosuppression Therapy
Science & Technology
business.industry
Reproducibility of Results
1103 Clinical Sciences
Glomerulonephritis
IGA

Hypertrophy
medicine.disease
business
Follow-Up Studies
Zdroj: Kidney international, 91(1), 235-243. Nature Publishing Group
ISSN: 0085-2538
Popis: Focal segmental glomerulosclerosis (FSGS) is a common finding in IgA nephropathy (IgAN). Here we assessed FSGS lesions in the Oxford Classification patient cohort and correlated histology with clinical presentation and outcome to determine whether subclassification of the S score in IgAN is reproducible and of clinical value. Our subclassification of lesions in 137 individuals with segmental glomerulosclerosis or adhesion (S1) identified 38% with podocyte hypertrophy, 10% with hyalinosis, 9% with resorption droplets within podocytes, 7% with tip lesions, 3% with perihilar sclerosis, and 2% with endocapillary foam cells. Reproducibility was good or excellent for tip lesions, hyalinosis, and perihilar sclerosis; moderate for podocyte hypertrophy; and poor for resorption droplets, adhesion only, and endocapillary foam cells. Podocyte hypertrophy and tip lesions were strongly associated with greater initial proteinuria. During follow-up of patients without immunosuppression, those with these features had more rapid renal function decline and worse survival from a combined event compared to S1 patients without such features and those without FSGS. Also in individuals with podocyte hypertrophy or tip lesions, immunosuppressive therapy was associated with better renal survival. In IgA nephropathy, the presence of podocyte hypertrophy or tip lesions, markers of podocyte injury, were reproducible. These features are strongly associated with proteinuria and, in untreated patients, carry a worse prognosis. Thus, our findings support reporting podocytopathic features alongside the S score of the Oxford Classification.
Databáze: OpenAIRE